Exercise eases fatigue for melanoma patients on immunotherapy
NCT ID NCT06985056
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study looks at whether a 12-week supervised exercise program can reduce fatigue and improve quality of life in adults with stage IIb-IV melanoma who are receiving immunotherapy or targeted therapy. Participants are randomly assigned to either an exercise group (online sessions plus some in-clinic training) or a control group with no structured exercise. The goal is to see if regular physical activity helps with tiredness, thinking skills, and overall well-being.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Essen
RECRUITINGEssen, 45147, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two immune boosters beat advanced melanoma?
- Drug duo takes on rare head and neck tumors
- Experimental cancer therapy targets tough tumors with radioactive precision
- Keytruda immune response trial aims to unlock cancer clues
- Experimental combo aims to supercharge cancer immunotherapy
- AI-Designed mRNA vaccine takes on advanced tumors in first human test